Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 7,993 | $902K |
| Open-market sale | 7 | 15,370 | $1.57M |
| Grant or award | 5 | 17,148 | |
| Option exercise | 26 | 50,350 | |
| Other acquisition / disposition | 2 | 5,731 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
35 Form 4 filings on record, the earliest from Oct 29, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Sakys - Officer | Option exercise | Common Stock | 2,840 | $92.99 | $264K | |
| John Sakys - Officer | Tax withholding / forfeiture | Common Stock | 1,243 | $92.99 | $116K | |
| John Sakys - Officer | Option exercise | Restricted Stock Units - 7 | 2,840 | $0.00 | - | |
| John Sakys - Officer | Option exercise | Common Stock | 793 | $0.00 | - | |
| John Sakys - Officer | Grant or award | Common Stock | 668 | $0.00 | - | |
| John Sakys - Officer | Open-market sale | Common Stock | 642 | $97.12 | $62K | |
| John Sakys - Officer | Option exercise | Restricted Stock Units - 5 | 793 | $0.00 | - | |
| John Sakys - Officer | Other | Non Qualified Stock Options | 4,087 | $0.00 | - | |
| John James Sullivan - Director | Gift | Common Stock | 2,000 | $0.00 | - | |
| Gary M. Owens - Officer | Grant or award | Common Stock | 11,559 | $0.00 | - | |
| Gary M. Owens - Officer | Open-market sale | Common Stock | 2,518 | $113.62 | $286K | |
| Gary M. Owens - Officer | Open-market sale | Common Stock | 2,551 | $111.98 | $286K |
This is as far as the anonymous view goes. Create a free account for all 35 MLAB filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Owens Gary M | Former Officer | 20,358 | $2.60M | View on EDGAR | |
| Owens Gary M | Former Officer | 20,000 | $2.45M | View on EDGAR | |
| - | - | - | - | View on EDGAR |
MESA LABORATORIES INC /CO/ (MLAB) had 15 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for MLAB runs to 35 Form 4 filings, the earliest from 2024-10-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of MLAB were filed in the last 90 days, totaling $902K.
7 insider sales of MLAB were filed in the last 90 days, totaling $1.57M.
This page tracks MLAB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MLAB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.